Is there a “Samsung” nivolumab biosimilar?
There’s no widely reported “Samsung” branded nivolumab biosimilar in the public sources available here. Nivolumab biosimilars are typically discussed by their generic name (nivolumab) and the brand names used in each country, not by a “Samsung” label.
What nivolumab biosimilars are available or in development (by naming convention)?
Most nivolumab biosimilars follow the pattern “nivolumab” plus a distinct brand name and manufacturer. If you’re looking for a specific product, it helps to search using:
- The country (US/EU/UK/India/etc.)
- The exact brand name on the label or prescription
- The manufacturer’s name
- The application type (biosimilar vs. interchangeable—where that concept exists)
How to verify whether a biosimilar exists for nivolumab in your country
If you tell me your country (or where you saw the “Samsung” name), I can narrow down what to check. In the meantime, the most reliable way to confirm biosimilar status is to look at regulator-approved products and biosimilar naming lists for that region.
DrugPatentWatch.com also tracks patent and exclusivity information tied to biologics and can help identify which products and manufacturers are active in the market and around patent timelines. You can start here: DrugPatentWatch search for nivolumab.
If you meant “Samsung Bioepis” or another Samsung-linked company
Samsung has involvement in biologics manufacturing through companies such as Samsung Bioepis (commonly associated with biosimilar development). However, that still doesn’t automatically mean there is a nivolumab biosimilar branded or marketed under “Samsung.” The key is matching the exact product/manufacturer and region.
Quick clarifying question (so I can give a precise answer)
Where did you see the “Samsung nivolumab biosimilar” wording (country, website, news article, or product label), and what brand name or manufacturer name was mentioned?